KNCV Knowledge Institute

The KNCV Knowledge Institute brings together the research and innovation expertise within our network. The Knowledge Institute aims to showcase our track record in research and innovation related to TB-associated health issues, and health systems.

KNCV Knowledge Institute objectives

The KNCV Knowledge Institute objectives are:

  1. To ensure that KNCV-supported innovations are at the forefront of research and development in the field, with a focus on quality assurance. Any innovations that prove to be effective will be effectively communicated and widely applied across KNCV-supported countries and beyond. This will facilitate national, regional, or global scale, as appropriate.
  2. To formalize relationships with universities and training institutes, to ensure that they are mutually beneficial and promote clear knowledge transfer. This involves consolidating and structuring the KNCV internship and exchange program. This will enhance KNCV’s expertise in TB and related health issues and support the development of future leaders in the field.

To establish KNCV as a reference centre for TB research, innovation, and project implementation, we are undertaking a systematic effort to raise awareness of our existing resources.

 

KNCV Knowledge Institute expected outcomes by 2025:

  • KNCV-supported research and innovations are easily accessible and visible on the KNCV websites worldwide and in KNCV communications
  • KNCV research network mapped, clearly displayed on KNCV websites worldwide and up to date
  • KNCV alumni network formed and engaged for dissemination and feedback
  • KNCV Knowledge Institute newsletter published at least twice a year and disseminated across KNCV worldwide, the KNCV research network and partners
  • All study protocols are reviewed by the KNCV ERB
  • The proceedings of KNCV ERB meetings are systematically documented
  • A social scientist involved in all qualitative research at KNCV 

 

More information

Read more about our Ethical Review Board (ERB), our Experts and our Publications.

Read more

  • 17/05/2023

    Saying goodbye and welcoming: two long esteemed colleagues

    Today we are saying goodbye to Jan Hendrik Richardus, Vice-Chair of the Board of Trustees (BoT) of…

    Lees meer
  • 06/04/2023

    Investing in TB vaccine research and development can save millions of lives

    Despite progress in TB control efforts, the global burden of TB remains high, with an estimated 10.6 million new cases…

    Lees meer
  • 04/04/2023

    Join us for a Round Table Discussion on BPaLM/BPaL

    On 12 April 2023, KNCV TB Plus will conduct an online Round Table Discussion on ‘Experience sharing: Preparation for programmatic…

    Lees meer
  • 30/03/2023

    KNCV Ethiopia’s Contributions and Recognition during the 17th Annual TB Research Conference (TRAC)

    KNCV TB Plus Ethiopia participated in 17th annual tuberculosis (TB) research conference (TRAC) and in the World TB Day commemoration, which…

    Lees meer
  • 24/03/2023

    250,000 patients to benefit from free access to short-course TB preventive treatment across seven countries

    Johannesburg, 24 March 2023 – The Unitaid-funded IMPAACT4TB Consortium, led by the Aurum Institute, announced today that it will…

    Lees meer
  • 24/03/2023

    Technical Brief: 5 Country Experiences with Digital Adherence Technologies

    Today is World TB Day, with Yes, We Can End TB as the theme for 2023. Digital Adherence Technologies (DATs)…

    Lees meer
  • 24/03/2023

    Why the world needs to start managing TB as a healthcare crisis

    by Mustapha Gidado, Executive Director, KNCV TB Plus. Increased political will and financial investment — plus the…

    Lees meer
  • 24/03/2023

    Tuberculosis: The Unseen Pandemic

    by Peter Sands, Executive Director, The Global Fund. Q: When do we ignore a deadly pandemic? A: When it’s called…

    Lees meer
  • 23/03/2023

    KNCV presented at the 34th EPHA Annual Conference in Ethiopia

    On 19 – 21 March 2023 KNCV Tuberculosis Foundation attended and presented at the 34th Ethiopian Public Health Associations…

    Lees meer
  • 23/03/2023

    Africa CDC and KNCV TB Plus Sign agreement to Promote Prevention and Control of Tuberculosis

    Addis Ababa, Ethiopia, and The Hague, The Netherlands, March 23, 2023 As the world commemorates World Tuberculosis Day tomorrow, with…

    Lees meer
  • 22/12/2022

    No More Pandemics: Training of national reference laboratory staff

    From 12-22 December 2022, in total eight staff members of the national reference laboratories from Kyrgyzstan, Tanzania and Vietnam were…

    Lees meer
  • Dream Fund project ‘No More Pandemics’

    The project “No more pandemics” aims to set a new standard for the diagnosis of infectious diseases and…

    Lees meer
  • 05/12/2022

    The story of Khasan and the shorter, improved TB regimen BPaL

    Khasan (1979): “I am a citizen of Uzbekistan, but I have been living in Russia with my family for several…

    Lees meer
  • 28/11/2022

    Congratulations to NTP Vietnam, for receiving the Ho Chi Minh Award on Science and Technology

    Last week, the National Tuberculosis Program (NTP) of Vietnam won the prestigious Ho Chi Minh Award on Science and Technology.

    Lees meer

KNCV has been fighting TB since its establishment in 1903. Over the past 120 years, the organization has acquired indispensable knowledge and experience in the field of effective TB prevention and care, resulting in pre-elimination in the Netherlands and significant contributions to global evidence generation, policy development and TB program implementation worldwide.

Our experts
KNCV governance framework and integrity
Our patroness
Partner with us

Sorry

De versie van de browser die je gebruikt is verouderd en wordt niet ondersteund.
Upgrade je browser om de website optimaal te gebruiken.